The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
- 9 December 2007
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 21 (6) , 1089-1108
- https://doi.org/10.1016/j.bpg.2007.10.020
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal CancerJournal of Clinical Oncology, 2007
- Cetuximab for the Treatment of Colorectal CancerNew England Journal of Medicine, 2007
- Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment GroupEuropean Journal Of Cancer, 2007
- Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemiaJournal of Clinical Investigation, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Towards a pan-European consensus on the treatment of patients with colorectal liver metastasesEuropean Journal Of Cancer, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)European Journal Of Cancer, 1999
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993